These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
| FORM 20-F |
[ ] REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended March 31, 2017
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
[ ] SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 001-35289
BURCON NUTRASCIENCE
CORPORATION
(Exact name of Registrant as specified in its
charter)
Yukon Territory
(Province or other
jurisdiction of incorporation or organization)
1946 West Broadway
Vancouver, British Columbia
V6J 1Z2
(Address of principal executive offices)
Jade Cheng
Phone: (604) 733-0896
Facsimile: (604) 733-8821
1946 West
Broadway
Vancouver, British Columbia V6J 1Z2
(Name, Telephone, E-mail and/or Facsimile number and Address of Company
Contact Person)
Securities registered or to be registered pursuant to Section
12(b) of the Act:
| Title of each class | Name of each exchange on which registered |
| Common Shares | Toronto Stock Exchange |
| The NASDAQ Stock Market LLC |
Securities registered or to be registered pursuant to Section 12(g) of the Act: None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
Indicate the number of outstanding shares of each of the issuers classes of capital or common stock as of the close of the period covered by the annual report.
37,827,175 Common Shares
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes
[ ] No [X]
If this report is an annual or transition report, indicate by
check mark if the registrant is not required to file reports pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934.
Yes [
] No [X]
Note - Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Exchange Act during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports) and (2) has been subject to such filing
requirements for the past 90 days.
Yes
[X] No [ ]
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation
S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the Registrant was required to submit and post such files).
Yes [ ] No
[X]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or an emerging growth company. See definition of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act. (Check one):
| Large accelerated filer [ ] | Accelerated Filer [ ] | Non-accelerated filer [ ] | Emerging growth company [X] |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
| US GAAP [ ] | International Financial Reporting Standards as issued | Other [ ] |
| by the International Accounting Standards Board [X] |
If "Other: has been checked in response to the previous
question, indicate by check mark which financial statement item the registrant
has elected to follow.
Item 17 [
] Item 18 [ ]
If this is an annual report, indicate by check mark whether the
registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [ ] No [X]
- 1 -
ANNUAL INFORMATION FORM, AUDITED ANNUAL CONSOLIDATED
FINANCIAL STATEMENTS AND MANAGEMENTS DISCUSSION AND
ANALYSIS
Annual Information Form
The Registrants Annual Information Form for the fiscal year ended March 31, 2017 is attached as Exhibit 99.1 to this Annual Report on Form 20-F and is incorporated herein by reference.
Audited Annual Consolidated Financial Statements
The Registrants audited annual consolidated financial statements for the fiscal year ended March 31, 2017, including the report of the independent registered public accounting firm with respect thereto, are attached as Exhibit 99.2 to this Annual Report on Form 20-F and are incorporated herein by reference.
Managements Discussion and Analysis
The Registrants Managements Discussion and Analysis for the fiscal year ended March 31, 2017 is attached as Exhibit 99.3 to this Annual Report on Form 20-F and is incorporated herein by reference.
Notice of Annual and Special Meeting and Management Proxy Circular
The Registrant's Notice of Annual and Special Meeting and Management Proxy Circular for the fiscal year ended March 31, 2017 is attached as Exhibit 99.4 to this Annual Report on Form 20-F and is incorporated herein by reference.
Additional Information
An Additional Information document is attached as Exhibit 99.5 to this Annual Report on Form 20-F and is incorporated herein by reference.
- 2 -
Cross Reference to Form 20-F
| Item No. | Exhibit | Pages | |
|
|
|||
| Item 1 | Identity of Directors, Senior Management and Advisers | N/A | N/A |
| Item 2 | Offer Statistics and Expected Timetable | N/A | N/A |
| Item 3 | Key Information | ||
| A. Selected financial data | 99.5 | 1 | |
| B. Capitalization and indebtedness | N/A | N/A | |
| C. Reasons for the offer and use of proceeds | N/A | N/A | |
| D. Risk factors | 99.1 | 51-59 | |
| 99.3 | 23-25 | ||
| Item 4 | Information on the Company | ||
| A. History and development of the company | 99.1 | Cover page, 5-16 | |
| 99.3 | 3-7 | ||
| B. Business overview | 99.1 | 16-51 | |
| 99.3 | 7-10 | ||
| C. Organizational structure | 99.1 | 5 | |
| 99.2 | 3 | ||
| D. Property, plants and equipment | 99.1 | 28-29, 38-39, 41 | |
| 99.2 | 10 | ||
| 99.5 | 2 | ||
| Item 4A | Unresolved Staff Comments | N/A | N/A |
| Item 5 | Operating and Financial Review and Prospects | ||
| A. Operating results | 99.1 | 5-11 | |
| 99.3 | 7-14, 15-16, 18 | ||
| B. Liquidity and capital resources | 99.2 | 1, 22 | |
| 99.3 | 14-18 | ||
| C. Research and development, patents and licenses, etc. | 99.1 | 28-29, 35-38 | |
| 99.3 | 10-13 | ||
| D. Trend information | 99.1 | 31-35 | |
| E. Off-balance sheet arrangements | 99.5 | 2 | |
| F. Tabular disclosure of contractual obligations | 99.5 | 2 | |
| G. Safe harbor | 99.1 | 1-4 | |
| Item 6 | Directors, Senior Management and Employees | ||
| A. Directors and senior management | 99.1 | 64-75 | |
| 99.4 | 6-11,18-19 | ||
| B. Compensation | 99.4 | 30-41 | |
| 99.5 | 3 | ||
| C. Board practices | 99.1 | 64-68, 79-81 | |
| 99.4 | 5-7, 21-22 | ||
| 99.5 | 3 | ||
| D. Employees | 99.1 | 39 | |
| E. Share Ownership | 99.1 | 64-68 | |
| 99.4 | 6-7,12-14,17,32-33,39-40, Schedule A | ||
| 99.5 | 3-4 | ||
| Item 7 | Major Shareholders and Related Party Transactions | ||
| A. Major shareholders | 99.4 | 1-2 | |
| 99.5 | 4 | ||
| B. Related party transactions | 99.1 | 75-76 | |
| 99.2 | 18-19 | ||
| 99.3 | 19-20 | ||
| 99.4 | 41-43 | ||
| C. Interests of experts and counsel | N/A | N/A |
- 3 -
| Item No. | Exhibit | Pages | |
| Item 8 | Financial Information | ||
| A. Consolidated Statements and Other Financial Information | 99.1 | 59 | |
| 99.2 | All | ||
| 99.3 | All | ||
| B. Significant changes | 99.2 | 24 | |
| Item 9 | The Offer and Listing | ||
| A. Offer and listing details | 99.1 | 60-62 | |
| 99.5 | 4 | ||
| B. Plan of distribution | N/A | N/A | |
| C. Markets | 99.1 | 5 | |
| D. Selling shareholders | N/A | N/A | |
| E. Dilution | N/A | N/A | |
| F. Expenses of the issue | N/A | N/A | |
| Item 10 | Additional Information | ||
| A. Share Capital | N/A | N/A | |
| B. Memorandum and articles of association | 99.5 | 5-7 | |
| C. Material contracts | 99.1 | 76-79 | |
| D. Exchange controls | N/A | N/A | |
| E. Taxation | 99.5 | 7-13 | |
| F. Dividends and paying agents | N/A | N/A | |
| G. Statement by experts | N/A | N/A | |
| H. Documents on display | 99.1 | 81 | |
| 99.3 | 1 | ||
| 99.4 | 43 | ||
| I. Subsidiary information | N/A | N/A | |
| Item 11 | Quantitative and Qualitative Disclosures About Market Risk | 99.2 | 21-23 |
| Item 12 | Description of Securities Other than Equity Securities | N/A | N/A |
|
|
|||
| Item 13 | Defaults, Dividend Arrearages and Delinquencies | N/A | N/A |
| Item 14 | Material Modifications to the Rights of Security Holders and | ||
| Use of Proceeds | N/A | N/A | |
| Item 15 | Controls and Procedures | 99.3 | 22 |
| Item 16 | [Reserved] | ||
| Item 16A. | Audit committee financial expert | 99.1 | 79-80 |
| Item 16B. | Code of Ethics | 99.4 | 20, Schedule C |
| Item 16C. | Principal Accountant Fees and Services | 99.1 | 80-81 |
| Item 16D. | Exemptions from the Listing Standards for Audit Committees | N/A | N/A |
| Item 16E. | Purchases of Equity Securities by the Issuer and Affiliated | ||
| Purchasers | N/A | N/A | |
| Item 16F. | Change in Registrants Certifying Accountant | N/A | N/A |
| Item 16G. | Corporate Governance | 99.5 | 13 |
| Item 16H. | Mine Safety Disclosure | N/A | N/A |
- 4 -
| Item No. | Exhibit | Pages | |
|
|
|||
| Item 17 | Financial Statements | N/A | N/A |
| Item 18 | Financial Statements | 99.2 | All |
| Item 19 | Exhibits | Exhibit Index | Exhibit Index |
- 5 -
SIGNATURE
The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.
| / S / Allan Yap | |
| Allan Yap | |
| Chairman and Chief Executive Officer |
Date: July 21, 2017
- 6 -
EXHIBIT INDEX
- 7 -
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|